BioVie ( (BIVI) ) just unveiled an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioVie Inc. announced a direct stock offering and a private placement, aiming to raise approximately $6.66 million through the sale of shares at $1.50 each. Additionally, the company will issue warrants exercisable for shares at $1.37 per share. These funds are intended for working capital and corporate purposes, with the offering closing expected on October 22, 2024. The company is focused on developing treatments for liver and neurological diseases.
For an in-depth examination of BIVI stock, go to TipRanks’ Stock Analysis page.